Tu1708 EFFICACY AND SAFETY OF ETRASIMOD IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ISOLATED PROCTITIS: A SUBGROUP ANALYSIS OF THE PHASE 3 ELEVATE UC 52 AND ELEVATE UC 12 TRIALS | Publicación